TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Orthocell Ltd ( (AU:OCC) ) has shared an update.
Orthocell Ltd has announced its 2025 Annual General Meeting (AGM) will be held both in-person at The University Club of Western Australia and online on November 6, 2025. Shareholders are encouraged to participate and can access meeting materials and voting instructions through the company’s website and ASX platform. This meeting is crucial for stakeholders as it provides an opportunity to engage with the company’s strategic direction and governance.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on the development of regenerative medicine products. The company specializes in innovative treatments for soft tissue injuries and musculoskeletal conditions, aiming to improve patient outcomes and quality of life.
Average Trading Volume: 607,456
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$379.2M
For a thorough assessment of OCC stock, go to TipRanks’ Stock Analysis page.